• Centene reported a strong Q1 2026 earnings beat, exceeding consensus expectations and raising its full-year 2026 adjusted EPS outlook to greater than $3.40.
  • This positive momentum follows the company's 2025 guidance withdrawal due to elevated utilization rates in individual and Medicaid plans, which previously caused a significant after-hours stock drop.
  • Today's rally reflects investors' reassessment of Centene's improved financial prospects and ongoing recovery.